investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

Positive:   Gene and cell ↓7.25   Biotechnology ↓3.75   Biopharma ↓3.33 «See more»   Disease: Eye  ↓1.69   Immunology ↓1.64   Country: Germany ↑0.18

RNA stock segment: trending tickers

ADTX ADiTx Therapeutics, Inc. - Common Stock -1.64% -1.64% 0 + Immunology, RNA, Medicine
+ My List
ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock -2.92% -2.92% 0 + Biopharma, RNA, Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/879407/000162828025017844/0001628280-25-017844-index.htm
8-K - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer)
+ My List
BNTC Benitec Biopharma Inc. - Common Stock -7.25% -7.25% 0 + Biopharma, Biotechnology, RNA, Medicine, Gene and cell

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1808898/000119312525157095/0001193125-25-157095-index.htm
8-K - Benitec Biopharma Inc. (0001808898) (Filer)
+ My List
CVAC CureVac N.V. - Ordinary Shares 0.18% 0.18% 0 + Country: Germany, RNA, Medicine, Biopharma

Last highlighted: 6-K Sec report https://www.sec.gov/Archives/edgar/data/1809122/000110465925063026/0001104659-25-063026-index.htm
6-K - CureVac N.V. (0001809122) (Filer)
+ My List
PRQR ProQR Therapeutics N.V. - Ordinary Shares -1.69% -1.69% 0 + Medicine, Biotechnology, Disease: Eye , RNA

Last highlighted: 6-K Sec report https://www.sec.gov/Archives/edgar/data/1612940/000110465925063073/0001104659-25-063073-index.htm
6-K - ProQR Therapeutics N.V. (0001612940) (Filer)
+ My List
TWST Twist Bioscience Corporation - Common Stock -2.31% -2.31% 0 + Biotechnology, RNA, Medicine

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1581280/000162828025022154/0001628280-25-022154-index.htm
10-Q - Twist Bioscience Corp (0001581280) (Filer)
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.